IP Verse

Pfizer Inc. V. Rubicon Research Private Ltd. - 1:24-cv-00626

Explore the details of the Pfizer Inc. V. Rubicon Research Private Ltd. case under case number 1:24-cv-00626 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-cv-00626
Filing Date
May 23, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Pfizer Ireland Pharmaceuticals -
Rubicon Research Private Ltd. -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 29, 2024ANSWER to 1 Complaint, COUNTERCLAIM against Pfizer Inc., Pfizer Ireland Pharmaceuticals by Rubicon Research Private Ltd..(Dorsney, Kenneth) (Entered: 07/29/2024)PACER Document
Aug 5, 2024NOTICE OF SERVICE of Defendant Rubicon Research Private Ltd.'s ANDA Production filed by Rubicon Research Private Ltd..(Dorsney, Kenneth) (Entered: 08/05/2024)PACER Document
Aug 8, 2024Letter to The Honorable Colm F. Connolly from Megan E. Dellinger regarding response to the Court's July 8, 2024 Order - re (20 in 1:24-cv-00621-CFC, 20 in 1:24-cv-00621-CFC, 12 in 1:24-cv-00625-CFC, 12 in 1:24-cv-00625-CFC, 13 in 1:24-cv-00626-CFC, 13 in 1:24-cv-00626-CFC, 12 in 1:24-cv-00623-CFC, 12 in 1:24-cv-00623-CFC, 13 in 1:24-cv-00627-CFC, 13 in 1:24-cv-00627-CFC, 12 in 1:24-cv-00624-CFC, 12 in 1:24-cv-00624-CFC, 13 in 1:24-cv-00622-CFC, 13 in 1:24-cv-00622-CFC) Order,, Set Deadlines,. (Dellinger, Megan) (Entered: 08/08/2024)PACER Document
Aug 12, 2024Order Setting In-Person Scheduling Conference: A Scheduling Conference is set for 10/2/2024 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 8/12/2024. Associated Cases: 1:24-cv-00621-CFC et al.(nmf) (Entered: 08/12/2024)PACER Document
Aug 19, 2024ANSWER to 14 Answer to Complaint, Counterclaim by Pfizer Inc., Pfizer Ireland Pharmaceuticals.(Dellinger, Megan) (Entered: 08/19/2024)PACER Document
Sep 30, 2024PROPOSED ORDER --[Proposed] Scheduling Order-- by Bristol-Myers Squibb Company, Pfizer Inc., Pfizer Ireland Pharmaceuticals, Pfizer Ireland Pharmaceutials. (Attachments: # 1 Letter to Judge Connolly)(Dellinger, Megan) (Entered: 09/30/2024)PACER Document
Sep 30, 2024PROPOSED ORDER --[Proposed] Scheduling Order-- by Bristol-Myers Squibb Company, Pfizer Inc., Pfizer Ireland Pharmaceuticals, Pfizer Ireland Pharmaceutials. (Attachments: # 1 Letter to Judge Connolly)(Dellinger, Megan) (Entered: 09/30/2024)Attachment
Sep 30, 2024SCHEDULING & CONSOLIDATION ORDER: These actions are consolidated for all purposes and all future filings shall be made in Lead Case No. 24-621-CFC ONLY. Joinder of Parties due by 9/26/2025. Amended Pleadings due by 9/26/2025. Fact Discovery completed by 3/25/2026. Expert Discovery due by 9/24/2026. Joint Claim Construction Brief due by 9/5/2025. A Markman Hearing is set for 10/22/2025 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 1/15/2027. A Final Pretrial Conference is set for 2/8/2027 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 2/16/2027 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 9/30/2024. Associated Cases: 1:24-cv-00621-CFC et al.(nmf) (Entered: 09/30/2024)PACER Document
May 29, 2024Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:24-cv-00621-CFC through 1:24-cv-00627-CFC (rjb)PACER Document
May 30, 2024Pro Hac Vice Fee - Credit Card Payment received for Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard. ( re 8 MOTION for Pro Hac Vice Appearance of Attorney Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard )( Payment of $ 150, receipt number ADEDC-4419020).(Dellinger, Megan) (Entered: 05/30/2024)PACER Document
May 30, 2024SO ORDERED, re (8 in 1:24-cv-00626-CFC, 8 in 1:24-cv-00627-CFC, 10 in 1:24-cv-00625-CFC, 11 in 1:24-cv-00622-CFC, 9 in 1:24-cv-00623-CFC, 10 in 1:24-cv-00624-CFC, 9 in 1:24-cv-00621-CFC) MOTION for Pro Hac Vice Appearance of Attorneys Dimitrios T. Drivas, John P. Scheibeler, and Joel L. Broussard, filed by Pfizer Inc., Pfizer Ireland Pharmaceutials, Bristol-Myers Squibb Company, Pfizer Ireland Pharmaceuticals. Ordered by Judge Colm F. Connolly on 5/30/2024. Associated Cases: 1:24-cv-00621-CFC et al.(kmd)PACER Document
May 31, 2024Pro Hac Vice Attorney John P. Scheibeler for Pfizer Inc. and Pfizer Ireland Pharmaceuticals added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam)PACER Document
May 31, 2024Pro Hac Vice Attorney Dimitrios T. Drivas for Pfizer Inc. and Pfizer Ireland Pharmaceuticals added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam)PACER Document
Jul 3, 2024Pro Hac Vice Fee - Credit Card Payment received for Stephen R. Auten and Jaimin H. Shah. ( re 11 MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten and Attorney Jaimin H. Shah )( Payment of $ 100, receipt number ADEDC-4444239).(Dorsney, Kenneth) (Entered: 07/03/2024)PACER Document
Jul 3, 2024SO ORDERED, re 11 MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Auten and Attorney Jaimin H. Shah filed by Rubicon Research Private Ltd. Signed by Judge Colm F. Connolly on 7/3/2024. (nmf)PACER Document
Jul 9, 2024Pro Hac Vice Attorneys Jaimin H. Shah and Stephen R. Auten for Rubicon Research Private Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)PACER Document
Jul 30, 2024Pro Hac Vice Attorney Joel L. Broussard for Pfizer Inc., Pfizer Ireland Pharmaceuticals, added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mws)PACER Document
Sep 30, 2024Case associated with lead case: Create association to 1:24-cv-00621-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 24-621-CFC ONLY. (nmf)PACER Document